OctreoScan positive Crohn's disease mimicking an ileal carcinoid tumor

Journal of Clinical Gastroenterology

Volumn 42, Issue 1, 2008, Pages 66-68

  Marko, Jamie ^a   Lamba, Reema ^b   Miller, Frank ^a   Buchman, Alan ^a   Spies, Stewart ^a   Nikolaidis, Paul ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Carcinoid; Crohn's disease; OctreoScan

Indexed keywords

PENTETREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; ILEUM TUMOR; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL INTESTINE RESECTION;

ADULT; CARCINOID TUMOR; CROHN DISEASE; FALSE POSITIVE REACTIONS; HUMANS; ILEAL NEOPLASMS; INDIUM RADIOISOTOPES; MALE; SOMATOSTATIN;

EID: 37549052868     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000212640.52359.ca     Document Type: Article

References (10)

1. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med. 2000;41:1704-1712.
2. Warner RR, O'Dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med. 2002;32:79-83.
3. Hanson MW. Scintigraphic evaluation of neuroendocrine tumors. Appl Radiol. 2001;30:11-17.
4. de Herder WW, Lamberts SW. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol. 2002;14:53-57.
5. Kwekkeboom D, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med. 2002;32:84-91.
6. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
7. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared to that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med. 1996;125:26-34.
8. Lebtahi R, Cadiot G, Sarda L, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med. 1997;38:853-858.
9. Gibril F, Reynolds JC, Chen CC, et al. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med. 1999;40:539-553.
10. Reubi JC, Mazzucchelli L, Laissue JA. Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology. 1994;106:951-959.